Niagen Bioscience, Inc. (FRA:OCD1)
Germany · Delayed Price · Currency is EUR 5.70
+0.10 (1.79%)
At close: Nov 28, 2025
Niagen Bioscience Market Cap
Niagen Bioscience has a market cap or net worth of €467.6 million as of December 1, 2025. Its market cap has decreased by -10.61% in one year.
Market Cap
467.60M
Enterprise Value
414.92M
Revenue
106.29M
Ranking
n/a
PE Ratio
26.86
Stock Price
€5.70
Market Cap Chart
Since June 24, 2008, Niagen Bioscience's market cap has increased from 67.39M to 467.60M, an increase of 593.81%. That is a compound annual growth rate of 11.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 467.60M | 19.21% |
| Dec 31, 2024 | 392.25M | 302.70% |
| Dec 29, 2023 | 97.41M | -17.00% |
| Dec 30, 2022 | 117.35M | -47.82% |
| Dec 31, 2021 | 224.88M | -7.52% |
| Dec 31, 2020 | 243.17M | 6.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |